Author:
Morgante G.,Ditto A.,La Marca A.,De Leo V.
Publisher
Oxford University Press (OUP)
Subject
Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine
Reference23 articles.
1. American Fertility Society (1997) Revised American Society for Reproductive Medicine classification of endometriosis. Fertil. Steril., 67, 817–821.
2. Barbieri, R.L. (1990) Endometriosis. Current treatment approaches. Drug, 39, 502–510.
3. Barbieri, R.L. (1991) The use of danazol as a treatment of endometriosis In Thomas, E., Rock, J. (eds), Modern Approaches to Endometriosis. Kluwer Academic Publishers, London, pp. 239–256.
4. Biberoglu, K.O. and Behrman, S.G. (1981) Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am. J. Obstet. Gynecol., 139, 645–650.
5. Cann, C.E., Henzel, M., Burry, K. et al. (1987) Reversible bone loss is produced by the GnRH agonist nafarelin. In Cohn, C.V., Martin, T.J. and Meunier P.J. (eds), Calcium Regulation and Bone Metabolism, Basic and Clinical Aspects. Vol. 9. Excerpta Medica, pp. 123–127.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献